Skip to main content
    N

    Neuronetics Inc (STIM)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $1.89
    -0.11 (-5.28%)

    Market Cap: $143.63M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    64%(21/33)
    Avg Surprise
    -0.41%
    Streak
    3 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.11
    Range$-0.11 - $-0.11
    1 analysts
    EPS Revisions
    2
    0
    7d
    2
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.11+2.9%
    60d ago$-0.11+2.9%
    30d ago$-0.11+2.9%
    7d ago$-0.11+2.2%
    Current$-0.11
    Revenue Consensus
    $40M
    Range$40M - $41M
    4 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.06
    Range$-0.06 - $-0.06
    1 analysts
    Revenue Consensus
    $47M
    Range$47M - $48M
    4 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.06---
    Sep 26EST
    		-$-0.11---
    Jun 26
    Reported Aug 11
    		$-0.05N/A+54.55%Beat+66.7%
    Mar 26
    Reported May 5
    		$-0.15$-0.17+11.76%Beat+28.6%
    Dec 25
    Reported Mar 17
    		$-0.10$-0.11+9.09%Beat+69.7%
    Sep 25
    Reported Nov 4
    		$-0.13$-0.12-8.33%Miss+70.5%
    Jun 25
    Reported Aug 5
    		$-0.15$-0.08-87.50%Miss+54.5%
    Mar 25
    Reported May 6
    		$-0.21$-0.12-75.00%Miss+22.2%
    Dec 24
    Reported Mar 4
    		$-0.33$-0.24-37.50%Miss-73.7%
    Sep 24
    Reported Nov 12
    		$-0.44$-0.23-91.30%Miss-33.3%
    Jun 24
    Reported Aug 12
    		$-0.33$-0.27-22.22%Miss-94.1%
    Mar 24
    Reported May 7
    		$-0.27$-0.31+12.90%Beat+28.9%
    Dec 23
    Reported Mar 5
    		$-0.19$-0.26+26.92%Beat+36.7%
    Sep 23
    Reported Nov 7
    		$-0.33$-0.28-17.86%Miss-17.9%
    Jun 23
    Reported Aug 8
    		$-0.17N/A+51.43%Beat+56.4%
    Mar 23
    Reported May 9
    		$-0.38$-0.39+2.56%Beat+7.3%
    Dec 22
    Reported Mar 7
    		$-0.30$-0.38+21.05%Beat-3.4%
    Sep 22
    Reported Nov 8
    		$-0.28$-0.42+33.33%Beat+9.7%
    Jun 22
    Reported Aug 2
    		$-0.39$-0.41+4.88%Beat-34.5%
    Mar 22
    Reported May 12
    		$-0.41$-0.40-2.50%Miss-32.3%
    Dec 21
    Reported Mar 8
    		$-0.29$-0.32+9.38%Beat-52.6%
    Sep 21
    Reported Nov 9
    		$-0.31$-0.30-3.33%Miss-72.2%
    Jun 21
    Reported Aug 3
    		$-0.29$-0.24-20.83%Miss+29.3%
    Mar 21
    Reported May 4
    		$-0.31$-0.31+0.00%Beat+50.8%
    Dec 20
    Reported Mar 2
    		$-0.19$-0.24+20.83%Beat+53.7%
    Sep 20
    Reported Nov 2
    		$-0.18$-0.28+35.71%Beat+51.4%
    Jun 20
    Reported Aug 4
    		$-0.41$-0.50+18.00%Beat-5.1%
    Mar 20
    Reported May 5
    		$-0.63$-0.46-36.96%Miss-50.0%
    Dec 19
    Reported Mar 3
    		$-0.41$-0.44+6.82%Beat-17.1%
    Sep 19
    Reported Nov 5
    		$-0.37$-0.43+13.95%Beat-27.6%
    Jun 19
    Reported Aug 6
    		$-0.39$-0.41+4.88%Beat+41.8%
    Mar 19
    Reported May 7
    		$-0.42$-0.40-5.00%Miss-2200.0%
    Dec 18
    Reported Mar 5
    		$-0.35$-0.37+5.41%Beat-
    Sep 18
    Reported Nov 6
    		$-0.29$-0.40+27.50%Beat-
    Jun 18
    Reported Aug 14
    		$-0.67$-0.88+23.86%Beat-
    Mar 18
    Reported Jun 29
    		$0.02$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-4.38EV/EBITDAN/A
    Price/FCF-12.25xFCF Yield-8.16%
    Profitability
    Profit Margin-19.60%Operating Margin-3.61%
    ROE-116.10%ROIC-21.23%
    Financial Health
    Debt/Equity3.46xInterest Coverage-2.26x
    Current Ratio1.88xQuick Ratio1.69x
    Trading Statistics
    Beta1.20Avg Volume873.50K
    52-Week High$3.4452-Week Low$0.80

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$2.12
    SMA 20$2.43
    SMA 50$2.71
    SMA 200$1.85
    EMA 10$2.15
    EMA 20$2.33
    EMA 50$2.43
    EMA 200$2.18

    MACD

    Line: -0.20Signal: -0.15Hist: -0.05

    ADX

    ADX: 36.8+DI: 9.5-DI: 38.1

    Aroon & PSAR

    Aroon Up12.0
    Aroon Down100.0
    PSAR$2.32

    Bollinger Bands

    Upper Band$3.14
    Lower Band$1.71
    %B Position5903%(Upper)
    Band Width0.12

    RSI (14-Day)

    Oversold
    22.8

    Momentum Oscillators

    Stoch %K1.4
    Stoch %D2.4
    Williams %R-99.5
    ROC (10d)-19.4%
    Momentum-0.46
    CCI (20d)-114.1
    MFI (14d)19.0

    Volatility Measures

    ATR (14d)$0.15(7.8%)
    StdDev (20d)0.36
    Hist Vol55.9%(High)

    Volume Flow

    VWAP$1.91
    OBV-9.8M
    AD Line-43.3M
    CMF (20d)-0.365

    Volume Metrics

    Avg Vol (20d)801.3K
    Vol Ratio1.0x
    VWMA (20d)$2.44

    Pivot Points

    R3$2.23
    R2$2.18
    R1$2.09
    Pivot Point$2.04
    S1$1.94
    S2$1.89
    S3$1.80

    Advanced Oscillators

    TSI-37.23
    Ultimate Osc22.5
    KST-256.49

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$41.57M$34.45M$41.78M$37.30M$38.11M$31.98M$22.49M$18.53M$16.45M$17.42M$20.31M$17.88M
    Cost of Revenue$20.34M$18.30M$20.07M$20.19M$20.35M$16.24M$7.60M$4.53M$4.27M$4.33M$4.54M$6.12M
    Gross Profit$21.22M$16.15M$21.70M$17.11M$17.76M$15.74M$14.89M$14.00M$12.18M$13.09M$15.77M$11.76M
    Operating Expenses$22.72M$25.15M$26.75M$24.43M$25.82M$26.75M$26.36M$21.73M$20.69M$19.95M$20.20M$20.64M
    R&D$1.34M$1.36M$1.67M$1.50M$1.80M$1.62M$5.77M$2.42M$2.23M$2.35M$2.21M$2.15M
    SG&A$11.40M$13.05M$13.34M$11.08M$12.15M$13.14M$10.78M$7.44M$6.15M$5.96M$6.28M$6.34M
    Operating Income$-1,501,000$-8,995,000$-5,043,000$-7,321,000$-8,058,000$-11,014,000$-11,469,000$-7,728,000$-8,507,000$-6,859,000$-4,427,000$-8,871,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$2.13M$2.81M$2.32M$2.21M$1.97M$1.92M$1.76M$6.15M$1.98M$1.83M$1.84M$1.18M
    Income Before Tax$-3,464,000$-10,780,000$-7,206,000$-9,401,000$-9,839,000$-12,689,000$-12,681,000$-13,341,000$-9,832,000$-7,873,000$-5,377,000$-9,391,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-3,464,000$-10,780,000$-7,206,000$-9,401,000$-9,839,000$-12,689,000$-12,681,000$-13,341,000$-9,832,000$-7,873,000$-5,377,000$-9,391,000
    EBITDA$-388,000$-6,974,000$-3,897,000$-6,097,000$-6,770,000$-9,667,000$-10,287,000$-6,571,000$-6,986,000$-5,326,000$-2,857,000$-7,570,000
    EBIT$-1,339,000$-7,975,000$-4,888,000$-7,195,000$-7,870,000$-10,767,000$-10,924,000$-7,189,000$-7,854,000$-6,047,000$-3,534,000$-8,207,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about STIM

    Government Contracts

    Gov Obligations (TTM)
    $10200
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    N/A
    Active Awards
    3
    New Awards (TTM)
    1
    Avg Remaining Term
    13.5 mo

    Top agency: Department of Defense at 100.0% of trailing twelve month obligations across 1 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    HT001425PE077Department of DefenseDefense Health Agency$10200Sep 27, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    BTIG maintains USD 6 target for Neuronetics stock at EUR 1.69

    BTIG has maintained its USD 6.00 price target for Neuronetics (STIM) stock, with the company's shares trading at EUR 1.69 on October 15...

    ad-hoc-news.de•10/15/26•Somewhat-Bullish

    Neuronetics announced EHR integration and Neuronetics stock fell 3.06 percent

    Neuronetics announced an integration of its TrakStar platform with AdvancedMD, an electronic health record system used by over 65,000 practitioners. Despite this operational milestone...

    AD HOC NEWS•10/8/26•Somewhat-Bearish

    Neuronetics stock gained 1.85 percent after Q2 revenue beat

    Neuronetics (STIM) stock rose 1.85% after reporting Q2 2026 revenue of $41.57 million, surpassing estimates by 3.20%. The company also narrowed its adjusted loss to $0.05 per share. Analysts have reaffirmed "Buy" ratings...

    AD HOC NEWS•10/6/26•Neutral

    Neuronetics stock fell 2.70 percent as Q2 growth emerged

    Neuronetics stock (STIM) closed down 2.70 percent at USD 2.16 on October 2, 2026, despite Q2 2026 revenue beating consensus by 3.20 percent. The company reported an adjusted loss of USD 0.05 per share...

    AD HOC NEWS•10/4/26•Somewhat-Bearish

    Long term debt to total assets ratio of Neuronetics, Inc. – HAN:NRC

    This article provides financial data for Neuronetics, Inc. (HAN:NRC) focusing on its long-term debt to total assets ratio. It lists the period, value...

    TradingView•9/30/26•Neutral

    STIM Valuation and Fair Value

    P/E
    -4.4x
    P/FCF
    -12.3x
    P/B
    7.7x
    See GNG's fair value

    STIM Profitability: Margins, ROIC and FCF

    Gross margin
    49.1%
    Operating margin
    -3.6%
    Net margin
    -19.6%
    ROIC
    -21.2%
    ROE
    -116.1%
    FCF margin
    -7.3%
    FCF yield
    -8.2%

    STIM Competitors

    CompanyTicker
    Quanterix CorpQTRX
    Cardiol Therapeutics Inc Class ACRDL
    Nkarta IncNKTX
    Repro Med Systems IncKRMD
    Protara Therapeutics IncTARA
    Nakamoto Inc.NAKA
    Organogenesis Holdings IncORGO
    Codexis IncCDXS

    Sector: Healthcare

    STIM Analyst Ratings

    Consensus
    Buy
    Analysts
    3
    Strong Buy
    1
    Buy
    2
    Hold
    0
    Sell
    0
    Strong Sell
    0

    STIM Bull Case vs Bear Case

    Bear case

    • STIM has a -19.6% net profit margin.
    • STIM beat EPS estimates in 37.5% of its last 8 reported quarters.
    • STIM has a debt-to-equity ratio of 3.5x.

    STIM Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -28.0%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.11
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    2 up, 0 down

    Frequently Asked Questions About STIM

    Does STIM pay dividends?

    Neuronetics Inc (STIM) does not currently pay a regular dividend.

    What is STIM's market cap?

    Neuronetics Inc (STIM) has a market capitalization of $143.63M with a current stock price of $1.89.

    Related stocks

    Sector: Healthcare

    All stocks starting with S

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In